MedTrace Logo

CARDIOCARE Prospective Clinical Study

NCT06334445 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 736

Last updated 2024-03-28

No results posted yet for this study

Summary

This is a prospective observational study to refine and validate risk stratification algorithms aimed at identifying elderly patients at higher risk of developing cardiotoxicity (us-ing risk factors and potential blood and stool biomarkers) and at assessing whether integrated patient-oriented behavioral and psychological interventions can mitigate, prevent or delay the onset of cardiotoxicity from chemotherapy.

Conditions

Interventions

BEHAVIORAL

Control group

Wearables/sensors and ePsycHeart App

BEHAVIORAL

Intervention group

Wearables/sensors and ePsycHeart App and eHealtHeart

Sponsors & Collaborators

  • European Institute of Oncology

    lead OTHER

Principal Investigators

  • Gabriella Pravettoni · European Institute of Oncology

Eligibility

Min Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-14
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06334445 on ClinicalTrials.gov